Author

Katelyn Chen

University of California San Diego

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Developmental Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Assay:proteomics· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Organism:human· 1 Organism:mouse· 1

Frequent Co-Authors

Andrea Zoey LiuiD· 2 shared Helena YuiD· 2 shared Mary Jean SunshineiD· 2 shared Robert A. J. SigneriD· 2 shared Yoon Joon KimiD· 2 shared Bernadette Anne Chua· 1 shared Carlo M. Ong· 1 shared Edward David Ball· 1 shared

Activity by Year

2025-2025 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersDevelopmental Biology

Andrea Zoey LiuORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Proteostasis Remodeling Across Development Defines Fetal, Neonatal, and Adult Hematopoietic Stem Cell States

Helena Yu, Yoon Joon Kim, Katelyn Chen, Andrea Zoey Liu, Mary Jean Sunshine, Robert A. J. Signer

The paper identifies distinct proteostasis programs in fetal, neonatal, and adult hematopoietic stem cells, showing how proteostasis changes during development and impacts stem cell function.

bioRxiv · Dec 15, 2025 · PreprintDevelopmental Biology

The Proteostasis Network is a Therapeutic Target in Acute Myeloid Leukemia

Kentson Lam, Yoon Joon Kim, Evelyn L. Tan, Carlo M. Ong, Andrea Zoey Liu, Fanny Zhou, Mary Jean Sunshine, Bernadette Anne Chua, Silvia Vicenzi, Katelyn Chen, Helena Yu, Pierce W. Ford, Jiehua Zhou, Yuning Hong, Eric J. Bennett, , Robert A. J. Signer

This study shows that proteasome inhibitors are ineffective in AML due to activation of HSF1 and autophagy, and that combining autophagy and proteasome inhibition effectively kills AML cells.

Blood · Oct 20, 2025Peer-reviewedCancer Biology